Purnamayanti Ni K D, Wicaksana Anggi L
Department of Medical Surgical Nursing, STIKES Buleleng, Bali, Indonesia.
Department of Medical Surgical Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Indian J Endocrinol Metab. 2021 Mar-Apr;25(2):86-92. doi: 10.4103/ijem.ijem_153_21. Epub 2021 Sep 8.
COVID-19 pandemic causes massive disruption of the global health system. The diabetic patients are the vulnerable parts population who are predicted to have a significant issue during the pandemic regarding the conventional type of consultation by face-to-face which may result in the higher risk of COVID-19 exposure. This study aims to observe the use of digital health services for diabetes management during COVID-19 pandemic.
A scoping review was conducted in PubMed, ScienceDirect, and Google Scholar during August until September 2020. The keywords that are used on the searching process are diabetes AND digital service OR telemedicine OR technology AND COVID-19. The criteria included the selection of scientific publication as an original research and reviews.
All published articles were gathered from 3 search engines; PubMed, Science Direct, and Google Scholar. The discussion explicates the practical considerations that are in accordance with the current condition of each country. In order to do so, the evidence is classified based on the level of global digital health framework in the developed and developing countries. It was found that the minimal level of digital health that connects diabetes patients with healthcare providers was at level 2, which is by using the video mode. The most advanced is at level 3B, which is applied by using the CGM devices, which provide active monitoring, diagnosis, and treatment based on timely clinical judgment.
It is feasible to utilize the digital health service during the COVID-19. This review is projected to be beneficial for the patient and health care providers to select the most feasible approach of digital health that merits the contextual resource.
新冠疫情对全球卫生系统造成了巨大破坏。糖尿病患者是弱势群体，预计在疫情期间，传统的面对面咨询方式会使他们面临重大问题，这可能导致感染新冠病毒的风险更高。本研究旨在观察新冠疫情期间数字健康服务在糖尿病管理中的应用。
于2020年8月至9月在PubMed、ScienceDirect和谷歌学术上进行了一项范围综述。在搜索过程中使用的关键词是糖尿病与数字服务或远程医疗或技术以及新冠疫情。纳入标准包括选择科学出版物作为原始研究和综述。
所有已发表的文章均从3个搜索引擎收集：PubMed、Science Direct和谷歌学术。讨论阐述了符合各国当前情况的实际考虑因素。为此，根据发达国家和发展中国家全球数字健康框架的水平对证据进行了分类。结果发现，将糖尿病患者与医疗服务提供者联系起来的数字健康最低水平为2级，即通过视频模式。最先进的是3B级，通过使用连续血糖监测（CGM）设备来应用，该设备基于及时的临床判断提供主动监测、诊断和治疗。
在新冠疫情期间利用数字健康服务是可行的。本综述预计将有助于患者和医疗服务提供者选择最适合具体情况资源的可行数字健康方法。
